NCT02571972View on ClinicalTrials.gov

Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 1, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

December 20, 2015

Conditions
Wet Macular DegenerationAge-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Interventions
DRUG

Dorzolamide-timolol

On enrollment, eligible patients will be started on topical dorzolamide-timolol in the study eye twice daily for the study duration

Trial Locations (1)

19107

Wills Eye Hospital / Mid Atlantic Retina, Philadelphia

All Listed Sponsors
collaborator

J. Arch McNamara Research Fund

OTHER

collaborator

Mid Atlantic Retina

OTHER

lead

Wills Eye

OTHER

NCT02571972 - Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. | Biotech Hunter | Biotech Hunter